outdated_browser_message

Items Tagged ‘imaging’

June 13th, 2016

FDA Approves New Imaging Agent for Detection of Recurrent Prostate Cancer

By

The United States Food and Drug Administration (FDA) has approved Axumin (fluciclovine F 18), an radioactive agent, to be used in positron emission tomography (PET) imaging for the detection of recurrent prostate cancer. Prostate cancer is the second leading cause of cancer-related deaths among men in the United States. If prostate cancer recurs following initial […]

View full entry

Tags: Axumin, fluciclovine F 18, imaging, News, PET, Prostate Cancer, recurrence, Refactory/Recurrent Prostate Cancer, scan